and who was wrong? a few hundred deluded biotech zombie shareholders and Horizon playing the greater fool game? Big deal. Are you off to the horizon board to skewer them or can you find some more constructive activities, like real investing?
So you have a nice "hobby" exposing #$%$ biotech. I think you'd do a lot more good exposing undervalued companies where people are working hard to create shareholder value.
I knew it! Pat myself on the back, thank you! I forgot all about HPTX after I posted about its Andromeda takeover and only stumbled over the PR from last fall about Andromeda and its "diapep" being FRAUDULENT and HPTX being taken for 570 MILLION dollars and then writing off 55 MILLION dollars!
And now Horizon shareholders get to foot the bill for a pathetic, effectively one trick pony -- I'm sure they're grateful! Bright side is, likely Horizon will dump HPTX's idiot management!
Goodbye all. This has been a mediocre board with few posts of value, but it was fun interfacing with the few of you who actually had insight into this company. Glad some of you made some $$. I expect the buyout to be completed in the next few weeks. rrtzrealmd - here's a final AHAHAHAHA to you. Nice job hiding after being so horribly wrong in absolutely everything you had to say about HPTX. They're now bringing in $120 million a year from just 500 patients - oops! Hope you learn from your mistakes.
Jetman - a few I like this year are: STML, GLYC, TGTX, CARA, VSTM, and OVAS. The last few years have been kind to most every investor, but I've been able to stay above average with the following algorithm. Do a stock screen where you look for "biotech" companies in the 100-700 million market cap range (schwab has a great screen) that have a Reuters average rating of "Buy" with 3-7 analysts following. This narrows the results to ~30 companies or so that are small and relatively below the radar. Then run these through a site where you can see projected price target (street insider has one you can use for free). Make a spreadsheet and order the results by highest potential increase if they meet their target price. Pick the top ten, look over the science, and if it makes sense then invest. I own ~12 companies with this algorithm and returns over the last 3 yrs are 50% annually. It's basically a venture capital model. Several of the stocks go down drastically, but each year there are 1-2 that go up 100-300% and these carry the portfolio. Happy to talk more about this if you're interested. Got lucky with HPTX, owning it from the beginning, and a few other winners have been TGTX, OVAS, GWPH, BLUE. I've been less lucky with MEIP and VSTM but the averages have been good.
My guess is the Horizon deal closes but yeah we'll see - there's still a month or so during which someone could outbid them. $1.1 billion seems a low-to-fair price for a company with $120 in revenue and the kind of patent protection they have, though obviously HPTX felt they were relatively fairly valued.
Every Low Life Lawyer is trying to sue already. Funny when you see these buyouts the same low life's line up to investigate and sue. Why do they sue when Buffet buys companies. Guess they are afraid of him.
Based on the filings today, it appears that there was no auction. I think there is an outside chance, maybe 20-30%, of a topping bid. Those who followed my bidding war call on SLXP made their year (well, at least I made my year). I'm not suggesting that there likely will be an overbid. In fact, as I've said, I think the probability is less than 50%. But, it is something to think about. I think this is a desirable asset, and I can think of a few other bidders who may want it. Good luck.
Wow. So misinformed. Why are Hyperion's expenses high? It's because they are (were) developing Ravicti for hepatic encephalopathy. What are the odds that Horizon, an ORPHAN drug company, is going to continue that development program? Low, to say the least. So it makes no sense to look at net profit as a proxy for what Horizon will be making off the drug going forward. And quarterly sales were still on the rise. So stop all the nonsense talk about suing, and lawyers. Law companies post junk on message boards all the time. They have no case against either Hyperion or Horizon, both of whom are getting a good deal, as are YOU, the shareholders!
Correction 7 million net per quarter. At current sale of 30 million per quarter 120 million per year. HZNP is paying almost 10 annual sales.
PPS on Jan. 6, 2015 was 23.34 shareholder from that date are getting 100% on their money. Looks like HZNP is paying 1 billion for a company that is netting 8 million per quarter.
Fields what other stocks are you following that are biotech? t
Get a clue. There was a bidding war, and Horizon is still getting an amazing deal. It's immediately accretive, which is why their share price shot up. Who exactly would they sue?